FDA Pulmonary/Rheumatology Division Sees Management Shakeup
Deputy Director for Safety Sally Seymour will become interim director of US FDA's Pulmonary, Allergy and Rheumatology Products Division following departure of division's top two managers, Badrul Chowdhury and Lydia Gilbert McClain.
You may also be interested in...
US FDA Hiring For Senior Staff Vacancies Boosted By Cures Act, Pilot Program – Gottlieb
Recent departures are 'business as usual' at the agency, Commissioner says.
New OND Director Could Be Hired Within Six Months, Woodcock Says
US FDA's Office of New Drugs has been without a permanent director for more than a year as it undergoes a significant restructuring.
More US FDA Departures: ODE II Director Rosebraugh, GI Division Director Griebel to Retire
FDA will have three leadership positions vacant in the Office of Drug Evaluation II when Curtis Rosebraugh leaves at the end of the month.